5 | Other expenses and income |
| | | | | | | | | | 2026 | | 2025 | | 2024 | for the year ended 30 June | | Rm | | Rm | | Rm | Includes: | | | | | | | | Derivative gains¹ | | | (1 426) | | (2 003) | | (2 364) | Translation losses/(gains) | | | 3 596 | | 897 | | 839 | Trade and other receivables | | | 587 | | 178 | | 485 | Trade and other payables | | | 106 | | 88 | | 241 | Foreign currency loans | | | 1 461 | | (238) | | 263 | Other² | | | 1 442 | | 869 | | (150) | Exploration expenditure and feasibility costs | | | 402 | | 509 | | 422 | Professional fees | | | 1 489 | | 1 821 | | 2 076 | Provision for rehabilitation | | | 200 | | (2 769) | | (590) | Expected credit losses (released)/raised | | | (87) | | (76) | | 189 | Other income3 | | | (4 139) | | (6 462) | | (4 025) |
| 1 | Relates mainly to the Group’s hedging activities and embedded derivatives (refer to note 35). |
| 2 | Relates mainly to the effect of the strengthening of the Rand on the translation of foreign operations and intergroup exposure on foreign currency loans. |
| 3 | During the prior year, Sasol and Transnet concluded a settlement agreement, resulting in a net receipt of R4,3 billion, which was the net between the amount owed to Sasol (Sasol proceedings) of R5,5 billion and the amount owed to Transnet (Transnet proceedings) of R1,2 billion. R3,9 billion related to compensation by Transnet for historical costs accounted for as a credit to Materials, energy and consumables used (refer to note 3), while the remaining R1,6 billion of the settlement was accounted for in Other income. |
Research and development expenditure amounting to R1 485 million (2025: R1 548 million; 2024: R1 513 million) was expensed and is included in Employee-related expenditure, Depreciation and amortisation and Other expenses and income in the income statement.
|